Small Molecule Drug Discovery Market to Grow at a CAGR of 9.5% to reach US$ 50,823.06 Million from 2020 to 2027

Small Molecule Drug Discovery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas); Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development); and Geography

Publication Month: May 2020 | Report Code: TIPRE00004774 | No. of Pages: 173 | Category: Pharmaceuticals | Status: Published
Covid

The small molecule drug discovery market was valued at US$ 24,976.14 million in 2019 and is projected to reach US$ 50,823.06 Mn by 2027; it is expected to grow at a CAGR of 9.5% from 2020 to 2027.

 

Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and, cost-effectiveness. The small molecule drug discovery market is expected to witness huge growth due to increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments. However, high drug development cost is expected to restrain the growth of the market during the forecast period.

 

Lucrative Regions for Small Molecule Drug Discovery Market

Lucrative Regions for Small Molecule Drug Discovery Market

Get more information on this report :


 

Market Insights

Rising Adoption of Small Molecules in Chronic Disease Treatments

As per the Centres for Disease Control (CDC), 6 in 10 adults suffer from a chronic condition, such as heart disease, diabetes, cancer, kidney disease, lung disease, or stroke in the US, costing US$ 3.5 trillion to the economy in the US annually for the treatment of these chronic diseases. Chronic diseases are the most significant cause of deaths worldwide, and the number is growing every year. For instance, as per the CDC, more than 1.6 million people are diagnosed with cancer every year in the US.

Small-molecule medicines are expected to provide effective treatment options for chronic diseases owing to their size and ability to cross cell barriers. They can also be designed to cross the blood-brain barrier to target neurological illnesses. Small molecules are expected to play a critical role in reducing the burden of chronic disease. In the coming years, small molecules are expected to help with the formulation of more efficient and effective treatments for chronic conditions.

 

Therapeutic Area -Based Insights

Based on therapeutic area, the small molecule drug discovery market is segmented into oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology, rare diseases, and other therapeutic areas. The oncology segment held a largest share of the market in 2019 owing to the increasing small molecule drug approvals and growing pipeline for the cancer therapeutics. Moreover, increasing investment in oncology is further driving the growth of the segment. For instance, In December 2019, Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental pathways in cancer, completed US$ 85 million Series C financing. However, the rare diseases segment is expected to register a higher CAGR in the market during the forecast period.

 

Global Small Molecule Drug Discovery Market, by Therapeutic Area – 2019 & 2027

Global Small Molecule Drug Discovery Market, by Therapeutic Area – 2019 & 2027

Get more information on this report :


 

Process/Phase -Based Insights

Based on process/phase, the small molecule drug discovery market is segmented into target discovery, target validation, lead generation and refinement, and preclinical development. The lead generation and refinement segment held the largest share of the global small molecule drug discovery market in 2019, owing to increasing investment in drug discovery and rising demand of cost-effective therapeutics. Moreover, the discovery of the target involves identification of disease modifying targets, which acts as one of the essential steps in drug discovery pipeline. However, the target discovery is anticipated to register the highest CAGR during the forecast period.

 

Strategic Insights

Collaborations and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand in order to expand its product portfolio.

The market players operating in the small molecule drug discovery market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

 

Small Molecule Drug Discovery Market – By Therapeutic Area

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Orthopedics
  • Immunology
  • Rare Diseases
  • Other Therapeutic Areas

Small Molecule Drug Discovery Market – By Process/Phase

  • Target Discovery
  • Target Validation
  • Lead Generation and Refinement
  • Preclinical Development

Small Molecule Drug Discovery Market– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America (SAM)
    • Brazil
    • Argentina
    • Rest of SAM

 

Company Profiles

  • Johnson and Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Boehringer Ingelheim International GmbH
  • Allergan Plc.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • MERCK KGaA
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Gilead Sciences, Inc.

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Small Molecule Drug Discovery Market – By Therapeutic Area

1.3.2        Global Small Molecule Drug Discovery Market – By Process/Phase

1.3.3        Global Small Molecule Drug Discovery Market – By Geography

2.             Small Molecule Drug Discovery Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Small Molecule Drug Discovery – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        Europe– PEST Analysis

4.2.2        Asia Pacific– PEST Analysis

4.2.3        Middle East & Africa

4.2.4        South and Central America

4.3       Expert Opinion

5.             Global Small Molecule Drug Discovery Market – Industry Dynamics

5.1       Market Drivers

5.1.1        Increasing Approval of Small Molecule Drugs

5.1.2        Growing Demand for R&D from Contract Organizations

5.1.3        Rising Adoption of Small Molecules in Chronic Disease Treatments

5.2       Market Restraints

5.2.1        High Drug Development Cost

5.3       Market Opportunities

5.3.1        Increasing Small Molecule-Based Pipeline

5.4       Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5       Impact analysis

6.             Small Molecule Drug Discovery Market – Global Analysis

6.1       Global Small Molecule Drug Discovery Market Revenue Forecast And Analysis

6.2       Global Small Molecule Drug Discovery Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Small Molecule Drug Discovery Market –  By Therapeutic Area

7.1       Overview

7.2       Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)

7.3       Oncology

7.3.1        Overview

7.3.2        Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.4       Central Nervous System

7.4.1        Overview

7.4.2        Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027  (US$ million)

7.5       Cardiovascular

7.5.1        Overview

7.5.2        Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.6       Respiratory

7.6.1        Overview

7.6.2        Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.7       Orthopedics

7.7.1        Overview

7.7.2        Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.8       Immunology

7.8.1        Overview

7.8.2        Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.9       Rare Diseases

7.9.1        Overview

7.9.2        Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.10    Other Therapeutic Areas

7.10.1     Overview

7.10.2     Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027  (US$ million)

8.             Small Molecule Drug Discovery Market –  By Process/Phase

8.1       Overview

8.2       Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)

8.3       Target Discovery

8.3.1        Overview

8.3.2        Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Target Validation

8.4.1        Overview

8.4.2        Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Lead Generation and Refinement

8.5.1        Overview

8.5.2        Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.6       Preclinical Development

8.6.1        Overview

8.6.2        Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027  (US$ Million)

9.             Small Molecule Drug Discovery Market – Geographic Analysis

9.1       North America: Small Molecule Drug Discovery Market

9.1.1        Overview

9.1.2        North America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

9.1.4        North America Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)

9.1.5        North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

9.1.5.1      US: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1.1       US: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1.2       US Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

9.1.5.1.3       US Skin aesthetic devices market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)

9.1.5.2      Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2.1       Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2.2       Canada Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

9.1.5.2.3       Canada Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)

9.1.5.3      Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.3.1       Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.3.2       Mexico Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

9.1.5.3.3       Mexico Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Million)

9.2       Europe: Small Molecule Drug Discovery Market

9.2.1        Overview

9.2.2        Europe: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Millions)

9.2.3        Europe: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018–2027 (USD Millions)

9.2.4        Europe: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.2.5        Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

9.2.5.1      Germany: Small Molecule Drug Discovery Market

9.2.5.1.1       Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.2.5.1.2       Germany: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.2.5.1.3       Germany: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.2.5.2      United Kingdom: Small Molecule Drug Discovery Market

9.2.5.2.1       United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.2.5.2.2       United Kingdom: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.2.5.2.3       United Kingdom: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.2.5.3      France: Small Molecule Drug Discovery Market

9.2.5.3.1       France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.2.5.3.2       France: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.2.5.3.3       France: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.2.5.4      Italy: Small Molecule Drug Discovery Market

9.2.5.4.1       Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.2.5.4.2       Italy: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.2.5.4.3       Italy: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.2.5.5      Spain: Small Molecule Drug Discovery Market

9.2.5.5.1       Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.2.5.5.2       Spain: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.2.5.5.3       Spain: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.3       Asia Pacific: Small Molecule Drug Discovery Market

9.3.1        Overview

9.3.2        Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.3.3        Asia Pacific: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.3.4        Asia Pacific: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.3.5        Asia Pacific: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

9.3.5.1      China: Small Molecule Drug Discovery Market

9.3.5.1.1       China: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.3.5.1.2       China: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.3.5.1.3       China: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.3.5.2      Japan: Small Molecule Drug Discovery Market

9.3.5.2.1       Japan: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.3.5.2.2       Japan: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.3.5.2.3       Japan: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.3.5.3      India: Small Molecule Drug Discovery Market

9.3.5.3.1       India: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.3.5.3.2       India: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.3.5.3.3       India: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.3.5.4      South Korea: Small Molecule Drug Discovery Market

9.3.5.4.1       South Korea: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.3.5.4.2       South Korea: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.3.5.4.3       South Korea: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.3.5.5      Australia: Small Molecule Drug Discovery Market

9.3.5.5.1       Australia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.3.5.5.2       Australia: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.3.5.5.3       Australia: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.4       Middle East and Africa: Small Molecule Drug Discovery Market

9.4.1        Overview

9.4.2        Middle East and Africa: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027  (USD Million)

9.4.3        Middle East and Africa Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

9.4.4        Middle East and Africa Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027  (USD Million)

9.4.5        Middle East and Africa: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

9.4.5.1      Saudi Arabia: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

9.4.5.1.1       Saudi Arabia: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

9.4.5.1.2       Saudi Arabia Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

9.4.5.1.3       Saudi Arabia Immunodiagnostics, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

9.4.5.2      UAE: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

9.4.5.2.1       UAE: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

9.4.5.2.2       UAE Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

9.4.5.2.3       UAE Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

9.4.5.3      South Africa: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

9.4.5.3.1       South Africa: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

9.4.5.3.2       South Africa Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

9.4.5.3.3       South Africa Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

9.5       South and Central America: Small Molecule Drug Discovery Market

9.5.1        Overview

9.5.2        South and Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027  (USD Million)

9.5.3        South and Central America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

9.5.4        South and Central America Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

9.5.5        South and Central America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

9.5.5.1      Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.5.5.1.1       Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.5.5.1.2       Brazil Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

9.5.5.1.3       Brazil Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027  (USD Million)

9.5.5.2      Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.5.5.2.1       Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

9.5.5.2.2       Argentina Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

9.5.5.2.3       Argentina Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

10.          Impact of COVID-19 Pandemic on Global Small Molecule Drug Discovery Market

10.1    North America: Impact Assessment of COVID-19 Pandemic

10.2    Europe: Impact Assessment of COVID-19 Pandemic

10.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

11.          Small Molecule Drug Discovery Market –Industry Landscape

11.1    Overview

11.2    Growth Strategies Done by the Companies in the Market, (%)

11.3    Organic Developments

11.3.1     Overview

11.4    Inorganic Developments

11.4.1     Overview

12.          Small Molecule Drug Discovery Market –Company Profiles

12.1    Pfizer Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    Bristol-Myers Squibb Company

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Merck KGaA

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    GlaxoSmithKline plc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    AstraZeneca

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Johnson & Johnson Services, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Gilead Sciences, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Teva Pharmaceutical Industries Ltd

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Boehringer Ingelheim International GmbH

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Allergan Plc.

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Products and Services

12.10.4   Financial Overview

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.          Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms


LIST OF TABLES

Table 1.             North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)

Table 3.             US Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

Table 4.             US Skin aesthetic devices market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)

Table 5.             Canada Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

Table 6.             Canada Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Million)

Table 7.             Mexico Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

Table 8.             Mexico Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Million)

Table 9.             Europe Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 10.          Europe Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 11.          Germany Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 ( USD Millions)

Table 12.          Germany Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 13.          United Kingdom Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)

Table 14.          United Kingdom Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 15.          France Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 16.          France Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 17.          Italy Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)

Table 18.          Italy Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 19.          Spain Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 20.          Spain Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 21.          Asia Pacific Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 22.          Asia Pacific Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 23.          China Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 24.          China Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 25.          Japan Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 26.          Japan Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 27.          India Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 28.          India Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 29.          South Korea Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 30.          South Korea Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 31.          Australia Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 32.          Australia Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 33.          North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

Table 34.          Middle East and Africa Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027  (USD Million)

Table 35.          Saudi Arabia Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

Table 36.          Saudi Arabia Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

Table 37.          UAE Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

Table 38.          UAE Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

Table 39.          South Africa Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

Table 40.          South Africa Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027  (USD Million)

Table 41.          South and Central America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)

Table 42.          South and Central America Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

Table 43.          Brazil Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

Table 44.          Brazil Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)

Table 45.          Argentina Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Million)

Table 46.          Argentina Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027  (USD Million)

Table 47.          Organic Developments Done By Companies

Table 48.          Inorganic Developments Done By Companies

Table 49.          Glossary of Terms, Small Molecule Drug Discovery Market

 


LIST OF FIGURES

Figure 1.           Small Molecule Drug Discovery Market Segmentation

Figure 2.           Small Molecule Drug Discovery Segmentation, By Region

Figure 3.           Global Small Molecule Drug Discovery Market Overview

Figure 4.           The Oncology Segment Held Largest Share and Rare Diseases Segment Expected To Grow With Highest Growth Rate

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Small Molecule Drug Discovery Market, By Geography (US$ Million)

Figure 7.           Global Small Molecule Drug Discovery Market, Industry Landscape

Figure 8.           Global Small Molecule Drug Discovery Market- Leading Country Markets (US$ Million)

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East & Africa PEST Analysis

Figure 13.        South and Central America PEST Analysis

Figure 14.        Small molecule drug discovery Market Impact Analysis of Driver and Restraints

Figure 15.        Global Small Molecule Drug Discovery Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Small Molecule Drug Discovery Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning of Key Players In Global Small Molecule Drug Discovery Market

Figure 18.        Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)

Figure 19.        Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 20.        Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 21.        Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 22.        Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 23.        Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 24.        Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 25.        Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 26.        Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 27.        Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)

Figure 28.        Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        North America: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Million)

Figure 33.        North America Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Million)

Figure 34.        North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

Figure 35.        US: Small Molecule Drug Discovery market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Europe: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Millions)

Figure 39.        Europe Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 40.        Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

Figure 41.        Germany Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 42.        United Kingdom Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 43.        France Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 44.        Italy Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 45.        Spain Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 46.        Asia Pacific: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Millions)

Figure 47.        Asia Pacific Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 48.        Asia Pacific: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

Figure 49.        China Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 50.        Japan Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 51.        India Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 52.        South Korea Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 53.        Australia Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 54.        Middle East and Africa: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Million)

Figure 55.        Middle East and Africa Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Million)

Figure 56.        North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

Figure 57.        Saudi Arabia: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

Figure 58.        UAE: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

Figure 59.        South Africa: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)

Figure 60.        South and Central America: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019)  (USD Million)

Figure 61.        South and Central America Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Million)

Figure 62.        South and Central America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

Figure 63.        Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        Impact of COVID-19 Pandemic In North American Country Markets

Figure 66.        Impact of COVID-19 Pandemic In European Country Markets

Figure 67.        Impact of COVID-19 Pandemic In Asia Pacific Country Markets

Figure 68.        Impact Of COVID-19 Pandemic In Rest of the World Market

Figure 69.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Small Molecule Drug Discovery Market

  1. Johnson and Johnson Services, Inc.
  2. Teva Pharmaceutical Industries Ltd
  3. Boehringer Ingelheim International GmbH
  4. Allergan Plc.
  5. Pfizer Inc.
  6. Bristol-Myers Squibb Company
  7. MERCK KGaA
  8. GlaxoSmithKline plc.
  9. AstraZeneca
  10. Gilead Sciences, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the small molecule drug discovery market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global small molecule drug discovery market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00004774
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery. When the biological target is well defined and understood, the rational design of small molecule ligands is possible. In the recent years, the small molecules have witnessed significant attention over biologics, as there is an increasing demand for these drugs.

The factors that are driving growth of the market are increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments propel the growth of the market.

The small molecule drug discovery market majorly consists of the players such as Pfizer Inc., Bristol-Myers Squibb Company, Merck KGaA, GlaxoSmithKline Plc, AstraZeneca, Johnson & Johnson Services, Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Boehringer Ingelheim International GmbH, and Allergan Plc.

Pricing